Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04024917 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis

Study acronym: COCOON
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 2025 to Dec 2026v20
  2. Primary and study completion dates: Jun 2025 to Dec 2025
    • Eligibility criteria shortened, about 5 words
    v19
  3. Primary and study completion dates: Jun 2024 to Jun 2025v18
  4. Re-verified, no change to tracked fieldsv17
  5. Primary and study completion dates: Dec 2023 to Jun 2024v16
Show 14 earlier versionsHide 14 earlier versions
  1. Primary and study completion dates: Dec 2022 to Dec 2023v15
  2. Primary completion date: Aug 2022 to Dec 2022
    • Study completion date: Oct 2022 to Dec 2022
    v14
  3. Primary completion date: Apr 2022 to Aug 2022
    • Study completion date: Jul 2022 to Oct 2022
    • Start date changed from estimate of Sep 2021 to Sep 21, 2021
    v13
  4. Start date: Jun 2021 to Sep 2021v12
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date: May 2021 to Jun 2021
    v11
  6. Start date: Mar 2021 to May 2021
    • Primary completion date: Feb 2022 to Apr 2022
    • Study completion date: May 2022 to Jul 2022
    • Eligibility criteria expanded, about 2 words
    v10
  7. Primary completion date: May 2021 to Feb 2022
    • Start date: Nov 2020 to Mar 2021
    • Study completion date: Aug 2021 to May 2022
    v9
  8. Start date: Oct 2020 to Nov 2020v8
  9. Start date: Sep 2020 to Oct 2020v7
  10. Re-verified, no change to tracked fieldsv6
  11. Start date: Jun 2020 to Sep 2020v5
  12. Start date: Mar 2020 to Jun 2020
    • Primary completion date: Feb 2021 to May 2021
    • Study completion date: May 2021 to Aug 2021
    v4
  13. Enrollment target: 59 to 60v3 Show 5 more changesShow less
    • Primary completion date: Jan 2021 to Feb 2021
    • Study completion date: Jul 2021 to May 2021
    • Start date: Feb 2020 to Mar 2020
    • Secondary endpoints: 16 to 18
    • Study description expanded, about 1 word
  14. Primary endpoints: 2 to 1
    • Eligibility criteria expanded, about 119 words
    • Secondary endpoints: 14 to 16
    • Study description shortened, about 1,249 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigator proposes to use the cardiac coherence technique to diminish anxiety before the surgery of a peritoneal carcinosis of colon or stomach or ovary and pseudomyxoma or peritoneal mesothelioma.
Trial Details
NCT Number NCT04024917
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Conditions
(from sponsor)		 Peritoneal Carcinomatosis, Pseudomyxoma Peritonei, Mesothelioma Peritoneum
Related terms Peritoneal Neoplasms, Pseudomyxoma Peritonei
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov